NSEGeneral Updates2d ago · 20 Jul 2026, 05:18 pm
General Updates
Marksans Pharma Limited · MARKSANS
✦ AI SummaryM&A
Marksans Pharma Limited has informed the Exchange about the acquisition of 100 percent share capital of ABCnow GmbH, a German company.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Marksans Pharma Limited has informed the Exchange about acquisition of 100 percent share capital of ABCnow GmbH.
Attachments (1)
📄pdf
Download →
MARKSANS_20072026171817_Closing_intimation.pdf
View document text
Date: 20 July 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relation Department Listing Department
Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Bandra-Kurla Complex,
Mumbai - 400001. Bandra (East), Mumbai - 400051.
Scrip Code: 524404 Symbol: MARKSANS
Sub: Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015– Acquisition of ABCnow GmbH.
Dear Sirs/Madam,
Further to our letter dated 08th July 2026, kindly be informed that the Company has completed the
process of acquiring 100% share capital of ABCnow GmbH based in Germany.
Kindly take the above in your record.
For Marksans Pharma Limited
Harshavardhan Panigrahi
Company Secretary
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W),
Mumbai - 400 053 Tel.: +91 22 4001 2000
E-mail: companysecretary@marksanspharma.com
www.marksanspharma.com